Adamas to Present at Upcoming BofA Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on May 11, 2021.

The fireside chat will be webcast live on Tuesday, May 11, 2021 at 11:45 am Eastern Time on the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. The replay will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Source: Adamas Pharmaceuticals, Inc.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  256.78
+4.89 (1.94%)
AAPL  332.27
+5.70 (1.75%)
AMD  516.13
+12.53 (2.49%)
BAC  62.69
+0.13 (0.21%)
GOOG  335.45
+5.06 (1.53%)
META  648.03
+3.65 (0.57%)
MSFT  495.63
+3.19 (0.65%)
NVDA  218.29
-0.07 (-0.03%)
ORCL  150.28
-2.66 (-1.74%)
TSLA  365.44
+1.88 (0.52%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.